Evaluation of Plasma Biomarkers to Predict Major Adverse Kidney Events in Hospitalized Patients With COVID-19
Description
CONCLUSIONS: TNFR1 and sTNFR2 are independently associated with MAKE in patients hospitalized with COVID-19, and can both also serve as predictors for adverse kidney outcomes.
